This is a non-core endpoint: only basic statistics are computed.

Other intestinal obstruction of newborn

Endpoint Browser

P16_OTH_INTESTINAL_OBSTRUCTION_NEWBO

No definition available.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — P76 Cause of death: ICD-10 — P76 2 out of 7 registries used, show all original rules.	11
4. Check minimum number of events None	11
5. Include endpoints None	11
6. Filter based on genotype QC (FinnGen only)	8

Control definitions (FinnGen only)

Control exclude: P16_DIGES_SYSTEM_DISORD_FETUS_NEWBO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: P7[5-8]
Name in latin: Alia obstructio intestini neonati

NAME	P16_OTH_INTESTINAL_OBSTRUCTION_NEWBO
CONTROL_EXCLUDE	P16_DIGES_SYSTEM_DISORD_FETUS_NEWBO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	P76
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	P76
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other intestinal obstruction of newborn based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	307	140	167
Only index persons	149	67	82
Unadjusted period prevalence (%)
Whole population	0.00	0.00	0.00
Only index persons	0.00	0.00	0.00
Median age at first event (years)
Whole population	-	0.00	0.00
Only index persons	0.00	0.00	0.00

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8	6	-
Unadjusted period prevalence (%)	0.00	0.00	-
Median age at first event (years)	17.72	0.14	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3011397) Hemoglobin [Presence] in Urine by Test strip

0.00

1.23

0.0

4.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

0.39

0.79

4.2

4.5

5.84

5.46

mmol/l

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

0.00

0.69

0.0

1.9

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

0.00

0.45

0.0

15.6

—

23.71

—

(3024354) Oxygen [Partial pressure] in Venous blood

0.00

0.45

0.0

15.6

—

5.35

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

0.00

0.45

0.0

15.6

—

5.74

—

(3037522) Nuclear Ab [Titer] in Serum

0.00

0.45

0.0

2.0

—

466.67

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

0.54

0.31

8.2

4.6

5.80

9.23

mm/h

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.23

0.0

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.23

0.0

1.1

—

(3019225) pH of Specimen

0.00

0.23

0.0

7.7

—

7.37

—

(3000991) Gas panel - Venous blood

0.00

0.22

0.0

18.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.00

0.22

0.0

3.8

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

0.67

0.13

12.8

7.3

137.20

112.89

u/l

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.38

0.13

6.2

4.0

70.80

63.35

nmol/l

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

3.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

0.00

0.0

6.8

—

54.04

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

3.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

2.2

—

(3034770) Mitochondria Ab [Titer] in Serum

0.00

0.0

2.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.0

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

0.00

-0.00

0.0

2.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.3

—

(3019069) Monocytes/Leukocytes in Blood

0.92

-0.00

16.6

9.6

6.80

8.92

—

(40761535) Cells panel - Urine sediment

0.00

-0.00

0.0

2.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

0.82

-0.00

16.6

12.4

4.12

3.29

e9/l

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

0.00

-0.00

0.0

1.9

—

(3008898) HLA-B27 [Presence]

0.00

-0.00

0.0

1.0

—

(3013115) Eosinophils [#/volume] in Blood

0.82

-0.00

16.8

10.5

0.09

0.21

e9/l

—

(3006504) Eosinophils/Leukocytes in Blood

0.96

-0.00

16.2

9.8

1.60

3.14

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.6

—

(3006315) Basophils [#/volume] in Blood

1.00

-0.00

16.8

10.3

0.02

0.04

e9/l

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

47.3

—

1.06

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

0.00

-0.00

0.0

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.00

-0.00

0.0

1.6

—

(3001604) Monocytes [#/volume] in Blood

1.00

-0.00

16.6

10.3

0.41

0.52

e9/l

—

(3019198) Lymphocytes [#/volume] in Blood

0.92

-0.00

16.8

10.0

2.01

2.16

e9/l

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

-0.00

0.0

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

-0.00

0.0

2.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint P16_OTH_INTESTINAL_OBSTRUCTION_NEWBO and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have P16_OTH_INTESTINAL_OBSTRUCTION_NEWBO.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: P16_OTH_INTESTINAL_OBSTRUCTION_NEWBO – Other intestinal obstruction of newborn

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other intestinal obstruction of newborn

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints